Dr. Klugherz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
118 Welsh Rd
Unit B
Horsham, PA 19044Phone+1 215-517-1038Fax+1 215-517-1049
Education & Training
University of Pennsylvania Health SystemFellowship, Cardiovascular Disease, 1995 - 1998- University of Pennsylvania Health SystemResidency, Internal Medicine, 1992 - 1995
Duke University School of MedicineClass of 1992
Harvard UniversityAB, Chenistry, Cum Laude, 1984 - 1988
Certifications & Licensure
PA State Medical License 1993 - 2024- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Philadelphia Magazine Castle Connolly, 2011-2014
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen Start of enrollment: 2023 Mar 13
Roles: Contact
Publications & Presentations
PubMed
- Effectiveness of low-dose rivaroxaban in preventing recurrent major adverse cardiovascular events in coronary artery disease: a systematic review and meta-analysis of ...Hussam Al Hennawi, Muhammad Khuzzaim Khan, Faisal Rasheed, Sushma Rathi, Mirha Ali
Coronary Artery Disease. 2024-11-01 - 1 citationsSafety and efficacy of clot-dissolving therapies for submassive pulmonary embolism: A network meta-analysis of randomized controlled trials.Hussam Al Hennawi, Anwar Khedr, Muhammad Khuzzaim Khan, Muhammad Talal Ashraf, Affan Sohail
Cardiovascular Revascularization Medicine. 2024-05-01 - 5 citationsFocal ST-segment elevation without coronary occlusion: myocardial infarction with no obstructive coronary atherosclerosis associated with COVID-19-a case reportCasey Meizinger, Bruce D. Klugherz
European Heart Journal. Case Reports. 2021-01-12
Other
- Possible role of long-term medical therapies to prevent restenosis following percutaneous coronary interventionKlugherz BD, Kolansky DM
http://www.uptodate.com/contents/possible-role-of-long-term-medical-therapies-to-prevent-restenosis-
UpToDate, Wolters Kluwer Health - 2012-03-01 - Use of intracoronary radiation to prevent restenosisKlugherz BD, Kolansky DM
http://www.uptodate.com/contents/use-of-intracoronary-radiation-to-prevent-restenosis
UpToDate, Wolters Kluwer Health - 2012-04-18
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
